Cargando…
Multi-targeted approach in the treatment of thyroid cancer
While accounting for only 1% of solid organ malignancies (9% in women), thyroid carcinoma is the most common malignancy of the endocrine system. Although most patients have a favorable prognosis, over 1,500 people will die from thyroid carcinoma each year. The spectrum of disease types range from pa...
Autores principales: | Pinchot, Scott N, Sippel, Rebecca S, Chen, Herbert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621417/ https://www.ncbi.nlm.nih.gov/pubmed/19209276 |
Ejemplares similares
-
Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions
por: Pinchot, Scott N., et al.
Publicado: (2009) -
ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature
por: Pinchot, Scott N, et al.
Publicado: (2009) -
Biochemical Determinants of Microbial Disease
por: Pinchot, Gifford B.
Publicado: (1954) -
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
por: Zhang, Ke, et al.
Publicado: (2023) -
The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)